These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 16379544)

  • 21. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
    Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Attitude towards and factors affecting uptake of population-based BRCA testing in the Ashkenazi Jewish population: a cohort study.
    Manchanda R; Burnell M; Gaba F; Sanderson S; Loggenberg K; Gessler S; Wardle J; Side L; Desai R; Brady AF; Dorkins H; Wallis Y; Chapman C; Jacobs C; Tomlinson I; Beller U; Menon U; Jacobs I
    BJOG; 2019 May; 126(6):784-794. PubMed ID: 30767407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic testing for breast cancer susceptibility: frequency of BRCA1 and BRCA2 mutations.
    Ganguly A; Leahy K; Marshall AM; Dhulipala R; Godmilow L; Ganguly T
    Genet Test; 1997; 1(2):85-90. PubMed ID: 10464631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors associated with decisions about clinical BRCA1/2 testing.
    Armstrong K; Calzone K; Stopfer J; Fitzgerald G; Coyne J; Weber B
    Cancer Epidemiol Biomarkers Prev; 2000 Nov; 9(11):1251-4. PubMed ID: 11097234
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Awareness and attitudes concerning BRCA gene testing.
    Mogilner A; Otten M; Cunningham JD; Brower ST
    Ann Surg Oncol; 1998; 5(7):607-12. PubMed ID: 9831109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening for founder mutations in BRCA1 and BRCA2 in unselected Jewish women.
    Metcalfe KA; Poll A; Royer R; Llacuachaqui M; Tulman A; Sun P; Narod SA
    J Clin Oncol; 2010 Jan; 28(3):387-91. PubMed ID: 20008623
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term follow-up of Jewish women with a BRCA1 and BRCA2 mutation who underwent population genetic screening.
    Metcalfe KA; Mian N; Enmore M; Poll A; Llacuachaqui M; Nanda S; Sun P; Hughes KS; Narod SA
    Breast Cancer Res Treat; 2012 Jun; 133(2):735-40. PubMed ID: 22240989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk of ovarian cancer in BRCA1 and BRCA2 mutation-negative hereditary breast cancer families.
    Kauff ND; Mitra N; Robson ME; Hurley KE; Chuai S; Goldfrank D; Wadsworth E; Lee J; Cigler T; Borgen PI; Norton L; Barakat RR; Offit K
    J Natl Cancer Inst; 2005 Sep; 97(18):1382-4. PubMed ID: 16174860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Receipt of genetic counseling recommendations among black women at high risk for BRCA mutations.
    Thompson HS; Sussner K; Schwartz MD; Edwards T; Forman A; Jandorf L; Brown K; Bovbjerg DH; Valdimarsdottir HB
    Genet Test Mol Biomarkers; 2012 Nov; 16(11):1257-62. PubMed ID: 23057569
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Coinheritance of BRCA1 and BRCA2 mutations with Fanconi anemia and Bloom syndrome mutations in Ashkenazi Jewish population: possible role in risk modification for cancer development.
    Koren-Michowitz M; Friedman E; Gershoni-Baruch R; Brok-Simoni F; Patael Y; Rechavi G; Amariglio N
    Am J Hematol; 2005 Mar; 78(3):203-6. PubMed ID: 15726604
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-counseling education materials for BRCA testing: does tailoring make a difference?
    Skinner CS; Schildkraut JM; Berry D; Calingaert B; Marcom PK; Sugarman J; Winer EP; Iglehart JD; Futreal PA; Rimer BK
    Genet Test; 2002; 6(2):93-105. PubMed ID: 12215248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experience with a nurse-driven genetic counseling pathway of Italian women with uninformative BRCA test result.
    Blondeaux E; Lambertini M; Buzzatti G; Bruzzone C; Baraga M; Pisani R; Del Mastro L; Pronzato P; Varesco L; Bonelli L
    J Genet Couns; 2023 Feb; 32(1):140-152. PubMed ID: 36036895
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Psychosocial predictors of BRCA counseling and testing decisions among urban African-American women.
    Thompson HS; Valdimarsdottir HB; Duteau-Buck C; Guevarra J; Bovbjerg DH; Richmond-Avellaneda C; Amarel D; Godfrey D; Brown K; Offit K
    Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1579-85. PubMed ID: 12496047
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation.
    Litton JK; Westin SN; Ready K; Sun CC; Peterson SK; Meric-Bernstam F; Gonzalez-Angulo AM; Bodurka DC; Lu KH; Hortobagyi GN; Arun BK
    Cancer; 2009 Apr; 115(8):1598-604. PubMed ID: 19280625
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health Care Disparities and Demand for Expanding Hereditary Breast Cancer Screening Guidelines in African Americans.
    Ciuro J; Beyer A; Fritzler J; Jackson N; Ahsan S
    Clin Breast Cancer; 2021 Jun; 21(3):e220-e227. PubMed ID: 33168447
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Service Delivery Model and Experiences in a Cancer Genetics Clinic for an Underserved Population.
    Woodson AH; Profato JL; Park M; Rizvi SH; Elsayegh N; Rieber AG; Arun BK
    J Health Care Poor Underserved; 2015 Aug; 26(3):784-91. PubMed ID: 26320913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study.
    Yoon SY; Thong MK; Taib NA; Yip CH; Teo SH
    Fam Cancer; 2011 Jun; 10(2):199-205. PubMed ID: 21318382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics.
    Kentwell M; Dow E; Antill Y; Wrede CD; McNally O; Higgs E; Hamilton A; Ananda S; Lindeman GJ; Scott CL
    Gynecol Oncol; 2017 Apr; 145(1):130-136. PubMed ID: 28162234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High Satisfaction and Low Distress in Breast Cancer Patients One Year after BRCA-Mutation Testing without Prior Face-to-Face Genetic Counseling.
    Sie AS; Spruijt L; van Zelst-Stams WA; Mensenkamp AR; Ligtenberg MJ; Brunner HG; Prins JB; Hoogerbrugge N
    J Genet Couns; 2016 Jun; 25(3):504-14. PubMed ID: 26531312
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reducing Disparities in Receipt of Genetic Counseling for Underserved Women at Risk of Hereditary Breast and Ovarian Cancer.
    Sutton AL; Hurtado-de-Mendoza A; Quillin J; Rubinsak L; Temkin SM; Gal T; Sheppard VB
    J Womens Health (Larchmt); 2020 Aug; 29(8):1131-1135. PubMed ID: 31794334
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.